Skip to main content

Table 1 Preoperative patient and tumor-related variables

From: Cirrhosis is not a contraindication to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in highly selected patients

  Patient 1 Patient 2 Patient 3
Age (years) 49 59 44
Gender M M F
Disease type LAMN LAMN with focal high grade Malignant mesothelioma
ECOG 0 0 0
ASA class III III IV
BMI (kg/m2) 37 24 32
Symptoms None None (right lower quadrant pain prompted laparoscopic appendectomy turned right hemicolectomy) Weight loss, abdominal distension, lower extremity edema
Etiology of cirrhosis HCV Alcohol HCV cirrhosis, GT1a
Bilirubin 0.5 0.51 0.3
INR 1.2 1.1 1.0
Ascites (yes/no) No No Yes
Child’s class A A A
Platelet count 164 207 259
Portal hypertension No Yes No
MELD score 8 8 6
Treatment for hepatitis C/cirrhosis None Alcohol cessation, propranolol for gastric varices None
Other significant PMH HTN, non-insulin-dependent diabetes None Insulin-dependent diabetes
  1. ECOG Eastern Cooperative Oncology Group, ASA American Society of Anesthesiology, BMI body mass index, INR international normalized ratio, MELD model for end-stage liver disease, PMH past medical history